IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts
-
Narrado por:
-
De:
Acerca de esta escucha
The status of the Republicans’ tax-cut bill and the Inflation Reduction Act — with ramifications for hospitals like HCA and Tenet, health insurers like Centene, electric-vehicle makers like Ford and Tesla and solar companies like First Solar — is among the key catalysts BI litigation and policy analysts are watching this week. The team also discussed President Donald Trump’s “Most-Favored Nation” drug-pricing executive order and the status of antitrust trials, specifically DOJ v. Google over search, and FTC v. Meta. We also discussed an FCC inquiry of EchoStar on May 12 asking for comments on whether the agency should reconsider a Sept. 20 decision by its wireless telecommunications bureau to extend the company’s deadlines to complete construction under a series of FCC licenses.
See omnystudio.com/listener for privacy information.